Otsuka ICU Medical outlays $500m to expand US manufacturing footprint
Otsuka ICU Medical is investing $500m into expanding its US-based IV manufacturing provision to improve long-term supply resiliency. The company, established …
Post
-
-
FDA clears iHealthScreen’s AI diabetic retinopathy screening software
Software as a Medical Device (SaMD) developer iHealthScreen has obtained US Food and Drug Administration (FDA) clearance for iPredict-DR, an artificial …
-
Roche secures CE Mark for Elecsys test to detect tuberculosis
Roche has secured the CE Mark for its Elecsys Interferon Gamma Release Assay (IGRA) TB blood-based test designed to detect …
-
TRiCares begins US IDE pivotal trial of TTVR system
TRiCares SAS has enrolled and treated the first patient in its TRICURE US IDE pivotal study of the Topaz transcatheter …
-
GE HealthCare and Mayo Clinic partner for new theranostics research study
GE HealthCare and Mayo Clinic are establishing a new research collaboration to advance personalised approaches to radioligand therapy (RLT) for …
-
Leo Cancer Care raises $65m for upright radiotherapy platform
Leo Cancer Care has raised $65m to advance manufacturing and commercial deployment activities surrounding its upright radiotherapy platform. The company’s oversubscribed …
-
Johnson & Johnson’s DE STSF platform secures FDA approval
Johnson & Johnson (J&J) has secured approval from the US Food and Drug Administration (FDA) for its Dual Energy Thermocool …
-
Philips expands ultrasound portfolio with AI-driven Alturion
Philips has expanded its ultrasound portfolio with the launch of the Alturion system, which features AI-powered workflows and is intended …
-
Resmed sharpens sleep care focus with $490m software business sale
Resmed has agreed to sell its MatrixCare business in a $490m cash deal to PE firm Frazier Healthcare Partners, allowing …
-
Ottobock expands neuro-orthotics portfolio with Fesia Technology acquisition
Ottobock has agreed to acquire Spanish medical device company Fesia Technology in a strategic move to expand its neuro-orthotics portfolio …
-
VB Spine to acquire rights to Augmedics’ CT-Fluoro technology
US-based medical technology company VB Spine has signed a definitive agreement with Augmedics to acquire the exclusive rights to the …
-
First patient enrolled in AtaCor’s ALARION-EV trial of EV-ICD system
AtaCor Medical has enrolled the first patient in its ALARION-EV pivotal trial, which is evaluating an investigational extravascular implantable cardioverter-defibrillator …
-
Beckman Coulter’s Alzheimer’s blood test obtains CE mark
Beckman Coulter Diagnostics has secured a CE mark for a blood test to aid in the clinical evaluation of amyloid …
-
De-risking drug formulation with AI predictive modelling
Bringing a new drug to market is one of the most time‑consuming and costly assignments within the pharma industry. From …
-
Alcon spends up to $200m to co-develop customisable cataract lenses with RxSight
Alcon and RxSight are pairing up to jointly develop a new adjustable lens to give surgeons the ability to fine-tune …
